Nasir H. Naqvi - Publications

Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Placebo-Controlled Trial.

Journal: Journal of attention disorders

Published: July 25, 2024

Open Label Pilot of Lorcaserin (a serotonin 2C-receptor agonist) for Cannabis Use Disorder.

Journal: Journal of substance use

Published: July 18, 2024

Preparing Residents to Combat the Opioid Epidemic: Insights from a Peer-Led Addictions Course.

Journal: Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry

Published: March 26, 2024

Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder.

Journal: The American journal of drug and alcohol abuse

Published: October 04, 2023

Neural correlates of drinking reduction during a clinical trial of cognitive behavioral therapy for alcohol use disorder.

Journal: Alcohol, clinical & experimental research

Published: August 09, 2023

Correction to "Drinking reduction during a clinical trial of cognitive behavioral therapy for alcohol use disorder is associated with reduction in anterior insula-bed nucleus of the stria terminalis resting state functional connectivity".

Journal: Alcohol, clinical & experimental research

Published: January 03, 2022

An open-label pilot study of pregabalin pharmacotherapy for alcohol use disorder.

Journal: The American journal of drug and alcohol abuse

Published: June 07, 2021

Drinking reduction during cognitive behavioral therapy for alcohol use disorder is associated with a reduction in anterior insula-bed nucleus of the stria terminalis resting-state functional connectivity.

Journal: Alcoholism, clinical and experimental research

Published: March 23, 2021

Open-label trial of a single-day induction onto buprenorphine extended-release injection for users of heroin and fentanyl.

Journal: The American journal on addictions

Published: September 25, 2020

Lorcaserin treatment for extended-release naltrexone induction and retention for opioid use disorder individuals: A pilot, placebo-controlled randomized trial.

Journal: Drug and alcohol dependence

Published: July 03, 2020

Quetiapine treatment for cannabis use disorder.

Journal: Drug and alcohol dependence

Published: June 20, 2020

Case Series: Rapid Induction Onto Long Acting Buprenorphine Injection for High Potency Synthetic Opioid Users.

Journal: The American journal on addictions

Published: August 29, 2019